Automation Engineer at Cytokinetics

South San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Cardiovascular, BiotechnologyIndustries

Requirements

BS degree in Biology, Bioengineering, Mechanical Engineering, or related field
2+ years of hands-on experience in developing and executing automated processes to support high-throughput screening, mass-spec sample preparation, as well as biochemical and cell-based profiling assays
Proficiency with automated liquid handlers and plate readers (e.g., Bravo, Hamilton platforms, Echo, Tempest, Envision, PHERAstar)
Experience operating integrated work cells and fluency in scheduling software (e.g., Green Button Go, Revolution, Overlord)
Experience with LIMS or ELN software for tracking automated workflows and managing data from automation platforms
Familiarity with CAD software (e.g., Solidworks, OnShape), 3D printing, extruded aluminum construction, and electronics prototyping
Proficiency in programming languages such as C#, Python, or similar
Experience in project management, project scoping, and requirements gathering

Responsibilities

Partner with scientists and engineers to transfer benchtop assays to automation platforms for increased throughput and efficiency
Develop protocols and workflows on automated liquid handling platforms and integrated work cells to deliver comprehensive automation solutions
Plan and execute validation tests to ensure automated processes meet qualification requirements
Execute end-to-end automated assay workflows, from reagent preparation through automation platform operation to report generation, following established best practices and guidelines
Troubleshoot system errors, perform routine maintenance, and provide technical support for automated systems
Identify and improve process inefficiencies to increase capacity and throughput
Implement documentation best practices and develop protocols and reference documents for automated procedures
Train users on automation platforms

Skills

Lab Automation

Liquid Handling

Automated Workflows

Assay Automation

Validation Testing

Lab Equipment

Automation Platforms

Screening Operations

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free